Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women-A meta-analysis

Nutrition

Volumn 29, Issue 1, 2013, Pages 8-14

  Zhang, Yun Bo ^a   Chen, Wen Hua ^a   Guo, Jing Jing ^a   Fu, Zheng Hai ^a   Yi, Cheng ^a   Zhang, Ming ^a   Na, Xiao Lin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Blood glucose; Body weight; Fasting insulin; Isoflavone supplementation

Indexed keywords

GLUCOSE; INSULIN; ISOFLAVONE;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT DURATION; WEIGHT REDUCTION;

AGED; BLOOD GLUCOSE; BODY WEIGHT; DIETARY SUPPLEMENTS; FASTING; FEMALE; HUMANS; INSULIN; ISOFLAVONES; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEANS;

EID: 84870838380     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.03.019     Document Type: Article

References (30)

1. Tufano A., Marzo P., Enrini R., Morricone L., Caviezel F., Ambrosi B. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. J Endocrinol Invest 2004, 27:648-653.
2. Gaspard U.J., Gottal J.M., Van den Brule F.A. Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects. Maturitas 1995, 21:171-178.
3. Sumino H., Ichikawa S., Yoshida A., Murakami M., Kanda T., Mizunuma H., et al. Effects of hormone replacement therapy on weight, abdominal fat distribution, and lipid levels in Japanese postmenopausal women. Int J Obes Relat Metab Disord 2003, 27:1044-1051.
4. Stojanovic N.D., Kwong P., Byrne D.J., Arnold A., Jagroop I.A., Nair D., et al. The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: a pilot study. Angiology 2003, 54:391-399.
5. Zhang Y., Na X., Li L., Zhao X., Cui H. Isoflavone reduces body weight by decreasing food intake in ovariectomized rats. Ann Nutr Metab 2009, 54:163-170.
6. Choi M.S., Jung U.J., Yeo J., Kim M.J., Lee M.K. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 2008, 24:74-81.
7. Goodman-Gruen D., Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 2001, 131:1202-1206.
8. Sites C.K., Cooper B.C., Toth M.J., Gastaldelli A., Arabshahi A., Barnes S. Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril 2007, 88:1609-1617.
9. Gardner C.D., Newell K.A., Cherin R., Haskell W.L. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001, 73:728-735.
10. Villa P., Costantini B., Suriano R., Perri C., Macri F., Ricciardi L., et al. The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status. J Clin Endocrinol Metab 2009, 94:552-558.
11. Crisafulli A., Altavilla D., Marini H., Bitto A., Cucinotta D., Frisina N., et al. Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause 2005, 12:186-192.
12. Aubertin-Leheudre M., Lord C., Khalil A., Dionne I.J. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study. Menopause 2007, 14:624-629.
13. Aubertin-Leheudre M., Lord C., Khalil A., Dionne I.J. Isoflavones and clinical cardiovascular risk factors in obese postmenopausal women: a randomized double-blind placebo-controlled trial. J Womens Health (Larchmt) 2008, 17:1363-1369.
14. Charles C., Yuskavage J., Carlson O., John M., Tagalicud A.S., Maggio M., et al. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 2009, 16:395-400.
15. Khaodhiar L., Ricciotti H.A., Li L., Pan W., Schickel M., Zhou J., Blackburn G.L. Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause 2008, 15:125-132.
16. Jayagopal V., Albertazzi P., Kilpatrick E.S., Howarth E.M., Jennings P.E., Hepburn D.A., Atkin S.L. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002, 25:1709-1714.
17. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., McQuay H.J. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
18. Garrido A., De la Maza M.P., Hirsch S., Valladares L. Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women. Maturitas 2006, 54:270-276.
19. Arjmandi B.H., Lucas E.A., Khalil D.A., Devareddy L., Smith B.J., McDonald J., et al. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J 2005, 4:8.
20. Weickert M.O., Reimann M., Otto B., Hall W.L., Vafeiadou K., Hallund J., et al. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. J Negat Results Biomed 2006, 5:11.
21. Puska P., Korpelainen V., Hoie L.H., Skovlund E., Smerud K.T. Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholesterolaemia: a double-blind, placebo-controlled trial of a yoghurt formulation. Br J Nutr 2004, 91:393-401.
22. Ricci E., Cipriani S., Chiaffarino F., Malvezzi M., Parazzini F. Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: a meta-analysis of randomized controlled trials. Menopause 2010, 17:1080-1086.
23. van Kruijsdijk R.C., van der Wall E., Visseren F.L. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009, 18:2569-2578.
24. Hemmingsen B., Lund S.S., Wetterslev J., Vaag A. Oral hypoglycaemic agents, insulin resistance and cardiovascular disease in patients with type 2 diabetes. Eur J Endocrinol 2009, 161:1-9.
25. Atteritano M., Marini H., Minutoli L., Polito F., Bitto A., Altavilla D., et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2007, 92:3068-3075.
26. Hall W.L., Vafeiadou K., Hallund J., Bugel S., Reimann M., Koebnick C., et al. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 2006, 83:592-600.
27. Ho S.C., Chen Y.M., Ho S.S., Woo J.L. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Menopause 2007, 14:905-912.
28. Liu Z.M., Chen Y.M., Ho S.C., Ho Y.P., Woo J. Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: a 6-mo double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes. Am J Clin Nutr 2010, 91:1394-1401.
29. Reynolds K., Chin A., Lees K.A., Nguyen A., Bujnowski D., He J. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 2006, 98:633-640.
30. Colacurci N., Chiàntera A., Fornaro F., de Novellis V., Manzella D., Arciello A., et al. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause 2005, 12:299-307.